| The global epidemiology of carbapenemase-producing Enterobacteriaceae D van Duin, Y Doi Virulence 8 (4), 460-469, 2017 | 879 | 2017 |
| Multidrug-resistant bacteria in the community: trends and lessons learned D Van Duin, DL Paterson Infectious disease clinics 30 (2), 377-390, 2016 | 629 | 2016 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 616 | 2018 |
| Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response A Panda, F Qian, S Mohanty, D Van Duin, FK Newman, L Zhang, S Chen, ... The Journal of Immunology 184 (5), 2518-2527, 2010 | 582 | 2010 |
| Ceftazidime/avibactam and ceftolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations D van Duin, RA Bonomo Clinical Infectious Diseases 63 (2), 234-241, 2016 | 551 | 2016 |
| Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 72 (7), e169-e183, 2021 | 537 | 2021 |
| Triggering TLR signaling in vaccination D Van Duin, R Medzhitov, AC Shaw Trends in immunology 27 (1), 49-55, 2006 | 485 | 2006 |
| Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes D Van Duin, KS Kaye, EA Neuner, RA Bonomo Diagnostic microbiology and infectious disease 75 (2), 115-120, 2013 | 479 | 2013 |
| Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical infectious diseases 74 (12), 2089-2114, 2022 | 412 | 2022 |
| Age-associated defect in human TLR-1/2 function D Van Duin, S Mohanty, V Thomas, S Ginter, RR Montgomery, E Fikrig, ... The Journal of Immunology 178 (2), 970-975, 2007 | 398 | 2007 |
| Bacterial infections after burn injuries: impact of multidrug resistance AM Lachiewicz, CG Hauck, DJ Weber, BA Cairns, D van Duin Clinical Infectious Diseases 65 (12), 2130-2136, 2017 | 343 | 2017 |
| Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin D Van Duin, A Casadevall, JD Nosanchuk Antimicrobial agents and chemotherapy 46 (11), 3394-3400, 2002 | 310 | 2002 |
| Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 75 (2), 187-212, 2022 | 292 | 2022 |
| Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? S Marshall, AM Hujer, LJ Rojas, KM Papp-Wallace, RM Humphries, ... Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02243-16, 2017 | 279 | 2017 |
| Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D van Duin, CJ Clancy Clinical Infectious Diseases, ciad428, 2023 | 277 | 2023 |
| Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients F Perez, D Van Duin Cleveland Clinic journal of medicine 80 (4), 225, 2013 | 274 | 2013 |
| Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms EA Neuner, J Sekeres, GS Hall, D van Duin Antimicrobial agents and chemotherapy 56 (11), 5744-5748, 2012 | 274 | 2012 |
| Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections EA Neuner, JY Yeh, GS Hall, J Sekeres, A Endimiani, RA Bonomo, ... Diagnostic microbiology and infectious disease 69 (4), 357-362, 2011 | 248 | 2011 |
| Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality LJ Rojas, M Salim, E Cober, SS Richter, F Perez, RA Salata, RC Kalayjian, ... Clinical Infectious Diseases 64 (6), 711-718, 2017 | 237 | 2017 |
| Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study D Van Duin, CA Arias, L Komarow, L Chen, BM Hanson, G Weston, ... The Lancet Infectious Diseases 20 (6), 731-741, 2020 | 231 | 2020 |
Vance Fowler在 duke.edu 的电子邮件经过验证
